---
title: "BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 | ONC Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/288251196.md"
description: "BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 | ONC Stock News"
datetime: "2026-06-01T02:00:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/288251196.md)
  - [en](https://longbridge.com/en/news/288251196.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/288251196.md)
---

# BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 | ONC Stock News

BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026 | ONC Stock News

### Related Stocks

- [ONC.US](https://longbridge.com/en/quote/ONC.US.md)

## Related News & Research

- [BeOne Medicines Signals Solid Tumor Breakout as Three Programs Near Phase 3](https://longbridge.com/en/news/288372773.md)
- [BeOne Medicines Ltd. - Sponsored ADR $ONC Shares Purchased by BNP Paribas Financial Markets](https://longbridge.com/en/news/288532322.md)
- [Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?](https://longbridge.com/en/news/288948995.md)
- [<![CDATA[What’s Trending in Oncology? A Discussion Following ASCO 2026 with Anne Marie Robertson from EVERSANA]]>](https://longbridge.com/en/news/288700390.md)
- [Here's Why Grail Stock Soared Higher in May (And Where the Company is Heading Now)](https://longbridge.com/en/news/288857741.md)